PMID: 702314Oct 1, 1978Paper

Evaluation of commercial ginseng products

Journal of Pharmaceutical Sciences
L E Liberti, A Der Marderosian

Abstract

The variation in panaxoside content of roots and commercial products of Panax ginseng and P. quinquefolium was evaluated by a new spectrodensitometric TLC method. The method is rapid and applicable to all commercial products, and it has a relative standard deviation of 6.4%. Panaxoside patterns of slurry-filled capsules and root extracts most closely resembled those of whole roots. Tablets did not contain detectable panaxosides while teas and granules for infusion yielded only low concentrations. The wide variation among these products indicates the need for more rigid control.

Citations

Jan 1, 1980·European Journal of Drug Metabolism and Pharmacokinetics·S E ChenE J Staba
Feb 17, 2010·International Journal of Emergency Medicine·D H PhuaK Heard
Nov 26, 2002·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H J KangM M Hammoud
Aug 5, 2003·Pharmacology, Biochemistry, and Behavior·David O Kennedy, Andrew B Scholey
Sep 21, 2000·Journal of Ethnopharmacology·M Davydov, A D Krikorian
Mar 30, 2002·Journal of the American College of Cardiology·Georgianne Valli, Elsa Grace V Giardina
Oct 8, 2003·Patient Education and Counseling·M Smith, H S Boon
Oct 11, 2001·Journal of Clinical Psychopharmacology·D EngelbergS Wiseman
Nov 18, 2000·Pharmacotherapy·I M Harris
Mar 24, 2000·Pharmacotherapy·J I Boullata, A M Nace
Jul 25, 2000·Pharmacotherapy·L G MillerM Knell
Mar 4, 2000·Sports Medicine·M S Bahrke, W R Morgan
Jan 1, 2011·African Journal of Traditional, Complementary, and Alternative Medicines : AJTCAM·J N EloffR van Brummelen
Jul 28, 2004·Journal of Herbal Pharmacotherapy·Jared Manning, Jeanette C Roberts
Jul 28, 2004·Journal of Herbal Pharmacotherapy·John I BakerDaniel E Keyler
Mar 27, 2003·The International Journal of Eating Disorders·James L RoerigKathryn Lancaster
Jan 22, 2010·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Sunhee ShinYun-Bae Kim
Jul 1, 1997·Biochemical Pharmacology·C N Gillis
Oct 10, 2006·Journal of Clinical Epidemiology·Joel J GagnierUNKNOWN CONSORT Group
Jun 20, 2006·Explore : the Journal of Science and Healing·Joel Gagnier, David Moher
Aug 29, 2003·Critical Care Nursing Clinics of North America·Yun Lu
Oct 23, 1997·Journal of the American Dietetic Association·H J Engels, J C Wirth
Feb 14, 2013·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·M H HaronA K Dasmahapatra
May 1, 1986·The Physician and Sportsmedicine·V Aronson
Jul 20, 2016·The American Journal of Chinese Medicine·Danyka BelangerValter Feyles
Feb 24, 2001·The Annals of Pharmacotherapy·T O Cheng
Jul 18, 2002·Journal of the American Veterinary Medical Association·Peter J Pascoe
Nov 2, 2005·Pediatric Blood & Cancer·Patrick J Mansky, Joyce M Koh
Mar 7, 2006·Journal of Pharmacological Sciences·Khaled RadadWolf-Dieter Rausch
Mar 17, 2018·BioMed Research International·Yingchun HeQingshan Zheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.